The Trump administration’s overarching message to the legions of people powering the federal government is simple: Leave.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...

A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super ...

Life expectancy in New York City has been falling. A new plan to address it includes basic income, prescribing parks, and ...

This is common. Those of us in research routinely store patient samples — blood, fluids, tissue, scrapings, and other ...

A ruling may come this month on UnitedHealth's motion to dismiss a lawsuit stemming from STAT reporting on the firm's use of ...

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...

The Howard Hughes Medical Institute abruptly ended a $60 million program to improve the retention of diverse college students ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...